BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23648420)

  • 1. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
    Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
    Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
    Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
    Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
    de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
    Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
    Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
    Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
    de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
    Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
    Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
    Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
    de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
    J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
    Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
    Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
    Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
    de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic cross-reactivity of venoms from medically important Loxosceles (Araneae) species in Brazil.
    Barbaro KC; Eickstedt VR; Mota I
    Toxicon; 1994 Jan; 32(1):113-20. PubMed ID: 9237343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia.
    Braz A; Minozzo J; Abreu JC; Gubert IC; Chávez-Olórtegui C
    Toxicon; 1999 Sep; 37(9):1323-8. PubMed ID: 10400292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
    Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
    Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies Against
    Calabria PAL; Shimokava-Falcao LHAL; Colombini M; Moura-da-Silva AM; Barbaro KC; Faquim-Mauro EL; Magalhaes GS
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30759862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial in vivo protection against Peruvian spider Loxosceles laeta venom by immunization with a multiepitopic protein (rMEPLox).
    Quispe RL; Jaramillo ML; Torres-Huaco F; Bonilla C; Isasi J; Guerra-Duarte C; Chávez-Olórtegui C
    Toxicon; 2022 Aug; 215():1-5. PubMed ID: 35660625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
    Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of astacin-like metalloproteases identified by transcriptomic analysis in Peruvian Loxosceles laeta spider venom and in vitro activity characterization.
    Medina-Santos R; Guerra-Duarte C; de Almeida Lima S; Costal-Oliveira F; Alves de Aquino P; Oliveira do Carmo A; Ferreyra CB; Gonzalez-Kozlova EE; Kalapothakis E; Chávez-Olórtegui C
    Biochimie; 2019 Dec; 167():81-92. PubMed ID: 31476328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.